2006Chinese Journal of NeuromedicineRequires access

Therapeutic effect of simvastatin on subarachnoid hemorrhage

Zhang Guo-zhon

Open publisher page 1 citations

Abstract

Objective To explore the therapeutic effect of simvastatin on subarachnoid hemorrhage(SAH).Methods Totally 128 SAH patients,who were admitted to our hospital from March 2003 to March 2005,were randomly divided into 2 groups:simvastatin group(n=64)which were treated with routine therapy,intravenous injection of nimodipine and oral or nasal feed of 20 mg simvastatin,twice a day;control group(n=64)which were treated with routine therapy,intravenous injection of nimodipine and oral taking of placebo instead of simvastatin,twice a day.Two weeks later all patients were given neurologic impairment score and head CT.Results Neurologic impairment scores in simvastatin group were significantly lower than those of control group(P0.05).The rate of cerebral vasospasm(CVS)is 6.25%(4/64)in simvastatin group and 17.19%(11/64)in control group,showing significant difference between the two(P0.01).Conclusion Simvastatin can evidently improve the neurological function and the therapeutic outcomes after SAH.

About this research paper

What this paper is about

Objective To explore the therapeutic effect of simvastatin on subarachnoid hemorrhage(SAH).Methods Totally 128 SAH patients,who were admitted to our hospital from March 2003 to March 2005,were randomly divided into 2 groups:simvastatin group(n=64)which were treated with routine therapy,intravenous injection of nimodipine and oral or nasal feed of 20 mg simvastatin,twice a day;control group(n=64)which were treated with routine therapy,intravenous injection of nimodipine and oral taking of placebo instead of simvastatin,twice a day.Two weeks later all patients were given neurologic impairment score and head CT.Results Neurologic impairment scores in simvastatin group were significantly lower than those of control group(P0.05).The rate of cerebral vasospasm(CVS)is 6.25%(4/64)in simvastatin group and 17.19%(11/64)in control group,showing significant difference between the two(P0.01).Conclusion Simvastatin can evidently improve the neurological function and the therapeutic outcomes after SAH.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the therapeutic effect of simvastatin on subarachnoid hemorrhage(SAH).Methods Totally 128 SAH patients,who were admitted to our hospital from March 2003 to March 2005,were randomly divided into 2 groups:simvastatin group(n=64)which were treated with routine therapy,intravenous injection of nimodipine and oral or nasal feed of 20 mg simvastatin,twice a day;control group(n=64)which were treated with routine therapy,intravenous injection of nimodipine and oral taking of placebo instead of simvastatin,twice a day.Two weeks later all patients were given neurologic impairment score and head CT.Results Neurologic impairment scores in simvastatin group were significantly lower than those of control group(P0.05).The rate of cerebral vasospasm(CVS)is 6.25%(4/64)in simvastatin group and 17.19%(11/64)in control group,showing significant difference between the two(P0.01).Conclusion Simvastatin can evidently improve the neurological function and the therapeutic outcomes after SAH.

Key concepts: Simvastatin, Medicine, Nimodipine, Subarachnoid hemorrhage, Anesthesia, Therapeutic effect, Placebo, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic effect of simvastatin on subarachnoid hemorrhage — Research Paper | ScholarLens